Type 2 diabetes with high blood sugar (Type 2 diabetes mellitus with hyperglycemia) is a common, clinically significant manifestation of type 2 diabetes where elevated blood glucose levels are the documented problem requiring evaluation, change in therapy, or acute management. Accurate ICD-10 coding for this condition guides clinical care plans, supports medical necessity on claims, and influences reimbursement, quality reporting, and risk adjustment.
For coding and revenue cycle professionals, precise selection between codes that indicate hyperglycemia, other acute diabetic complications, or uncomplicated diabetes reduces denials and audit exposure. This guide explains when to assign E11.65, when to choose alternative codes, documentation expectations, payer considerations, and practical workflows to improve first-pass acceptance.
The ICD-10-CM Code for Type 2 diabetes mellitus with hyperglycemia is E11.65.
Type 2 diabetes mellitus with hyperglycemia is the clinical designation used when a person with type 2 diabetes has documented elevated blood glucose levels that warrant clinical attention but without documentation of diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). E11.65 identifies the chronic disease (type 2 diabetes) and specifies the current manifestation as hyperglycemia. Use of E11.65 communicates that hyperglycemia is present and is the primary reason for evaluation, medication adjustment, or outpatient management within the encounter. This code belongs to the E11 category in ICD-10-CM, which groups diagnoses for type 2 diabetes mellitus and its specified manifestations.
Use E11.65 when a patient with established type 2 diabetes presents in clinic with elevated blood glucose readings documented by point-of-care testing or lab results and the clinician adjusts oral agents or insulin, increases monitoring, or documents the need for tighter glycemic control. Document the specific glucose values, current regimen, and rationale for change.
Assign E11.65 for ED encounters where a patient has significant hyperglycemic symptoms (polyuria, polydipsia, dehydration) and elevated glucose is confirmed, but no diagnostic criteria for DKA or HHS are met and no alternative complication code is documented. Record assessed vitals, labs, and disposition (treat-and-release, observation, or admission rationale).
When a follow-up visit documents continued hyperglycemia despite adherence to prescribed therapy and the clinician documents therapeutic optimization or education focused on hyperglycemia, E11.65 is appropriate. Ensure documentation includes evidence of adherence assessment and specific plan.
If treatment decisions (starting insulin, changing class of oral agent) are driven by documented elevated glucose rather than by an acute complication, code E11.65 to reflect the reason for medication management. Include baseline labs, targeted goals, and patient education in the record.
Do not use E11.65 if the encounter documents DKA or diabetic coma. Select the appropriate type 2 diabetes code that specifies ketoacidosis (for example, the E11 category code indicating ketoacidosis) and include accompanying codes for metabolic disturbances as required by documentation.
If the clinical record documents HHS or hyperosmolarity with altered mental status, do not assign E11.65. Use the code that explicitly represents type 2 diabetes with hyperosmolarity and related acute complications, reflecting the severity and resource use.
If hyperglycemia is due to medication, endocrine disease, pancreatic disease, or other identifiable cause, choose the E08 (diabetes due to underlying condition) or E09 (drug- or chemical-induced diabetes) category as documented. E11.65 is inappropriate when etiology is secondary.
If the chart specifies type 1 diabetes with hyperglycemia, use the corresponding type 1 diabetes code that indicates hyperglycemia (for example, E10.65). Do not assign E11.65 when the provider documents type 1 diabetes.
| Condition | Code | When It Is Used | When It Is Not Used |
|---|---|---|---|
| Type 2 diabetes mellitus with hyperglycemia | E11.65 | When a patient with type 2 diabetes has documented elevated blood glucose requiring evaluation or change in therapy without DKA or HHS | Do not use when DKA, HHS, secondary diabetes, or type 1 diabetes is documented |
| Type 2 diabetes mellitus without complications | E11.9 | When type 2 diabetes is managed and no acute manifestations (including hyperglycemia) are documented during the encounter | Not used if hyperglycemia, DKA, HHS, or any diabetes complication is documented |
| Type 1 diabetes mellitus with hyperglycemia | E10.65 | When the patient is explicitly documented as having type 1 diabetes and hyperglycemia is present and addressed | Not used for patients documented as type 2 diabetes or for secondary diabetes causes |
| Diabetes due to underlying condition (secondary) | E08.x | When hyperglycemia is explicitly linked to another underlying condition (e.g., pancreatic disease, endocrine disorder) and that etiology is documented | Not used when type 1 or type 2 diabetes is the documented diagnosis or when DKA/HHS codes are required |
Include the numerical glucose result, specimen type (point-of-care or lab), and date/time. Payers and auditors expect objective evidence supporting E11.65; numeric values and trends strengthen medical necessity.
The chart must specify "type 2 diabetes" and note "hyperglycemia" or "elevated blood glucose" in the assessment/diagnosis. Avoid ambiguous phrasing that forces coders to default to nonspecific codes.
Document why the encounter addressed hyperglycemia (medication change, IV fluids, ED evaluation), the treatment provided, and follow-up plans. Linking the diagnosis to treatment supports reimbursement and medical necessity.
Document related comorbid conditions (e.g., renal impairment, infection) and the clinical complexity of decisions made. Accurate comorbidity capture impacts risk adjustment and justifies higher-level services when appropriate.
Implement CombineHealth.ai's AI-powered platform for automated coding validation and claim scrubbing to detect missing specificity, mismatched diabetes type, and documentation gaps before submission. This reduces denials and improves first-pass acceptance.
Coding for type 2 diabetes with high blood sugar has direct impact on revenue cycle outcomes:
Accurate ICD-10 coding is critical for healthcare revenue cycle performance. CombineHealth.ai's AI-powered platform helps RCM teams ensure coding accuracy, reduce denials, and optimize reimbursement through intelligent denial management and claim validation. CombineHealth.ai's intelligent platform provides automated claim scrubbing and coding validation to catch errors before submission, reducing denials and improving first-pass acceptance rates.
Q1: What is the ICD-10 code for type 2 diabetes with high blood sugar?
The ICD-10-CM code for type 2 diabetes with high blood sugar is E11.65. Use this code when a patient with type 2 diabetes has documented hyperglycemia that is the focus of the encounter and no DKA or HHS is present.
Q2: When should I use E11.65 vs related codes?
Use E11.65 when the chart documents type 2 diabetes and hyperglycemia without acute complications. Use type 2 diabetes without complications (E11.9) when no hyperglycemia or other manifestation is documented. Use type 1 diabetes with hyperglycemia (E10.65) when the provider documents type 1 diabetes. For DKA or HHS, select the diabetes code that specifies those acute complications rather than E11.65. If diabetes is secondary to another condition, use the appropriate secondary diabetes category (E08.x or E09.x).
Q3: What documentation is required when coding for type 2 diabetes with high blood sugar?
Document the diabetes type (type 2), explicit statement of hyperglycemia or elevated blood glucose, numeric glucose values and specimen source, treatment actions (medication changes, IV therapy, education), assessment tying hyperglycemia to the visit, and follow-up plan. Also note adherence assessment and any contributing factors (infection, medication nonadherence).
Q4: What are common denial reasons when coding for type 2 diabetes with high blood sugar?
Denials commonly arise from lack of specificity (no documented hyperglycemia), mismatch between documented diabetes type and code selected, or selection of E11.65 when DKA/HHS should have been coded. For strategies to manage and prevent denials, see our guide on denial management.